Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12EKB | ISIN: CA09073K1084 | Ticker-Symbol: 20B
Frankfurt
21.11.24
08:10 Uhr
0,125 Euro
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOMARK DIAGNOSTICS INC Chart 1 Jahr
5-Tage-Chart
BIOMARK DIAGNOSTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,1250,17412:32

Aktuelle News zur BIOMARK DIAGNOSTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
05.11.Biomark Diagnostics Inc: Biomark boasts of liquid biopsy platform detection2
05.11.BioMark Diagnostics, Inc.: BioMark Expands Its Liquid Biopsy Platform with Two Groundbreaking Publications in Breast Cancer Detection251Vancouver, British Columbia--(Newsfile Corp. - November 5, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) ("BioMark"), a leading developer of liquid biopsy tests for early...
► Artikel lesen
24.09.Biomark Diagnostics Inc: Biomark's metabolomics paper published in Cancers10
24.09.BioMark Diagnostics, Inc.: BioMark Diagnostics and Principal Investigators Publish an Important Approach Using Metabolomics and ML to Identify Biomarkers for NEN279Vancouver, British Columbia--(Newsfile Corp. - September 24, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF), a leading developer of liquid biopsy tests for early cancer detection...
► Artikel lesen
10.09.Biomark Diagnostics Inc: Biomark tests 5,400 subjects via lunger cancer assay1
10.09.BioMark Diagnostics, Inc.: BioMark Diagnostics Completes Testing of over 5,400 Subjects as Part of a Validation Study for Early Lung Cancer Detection198Vancouver, British Columbia--(Newsfile Corp. - September 10, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF), a leading developer of liquid biopsy tests for early cancer detection...
► Artikel lesen
BIOMARK DIAGNOSTICS Aktie jetzt für 0€ handeln
26.08.BioMark Diagnostics, Inc.: Biomark Diagnostics to Showcase Innovative Liquid Biopsy Technology at H.C. Wainwright's 26th Annual Global Investment Conference in New York437Vancouver, British Columbia--(Newsfile Corp. - August 26, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF), a leading developer of liquid biopsy tests for early cancer detection...
► Artikel lesen
31.07.Biomark Diagnostics Inc: Biomark receives U.S. patent for SAT110
31.07.BioMark Diagnostics, Inc.: The U.S. Patent and Trademark Office Grants BioMark Patent That Expands Its Claims Covering Its Legacy Liquid Biopsy Assay308Vancouver, British Columbia--(Newsfile Corp. - July 31, 2024) - BioMark Diagnostics Inc., (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company"), a leading developer of liquid biopsy...
► Artikel lesen
15.07.BioMark Diagnostics, Inc.: BioMark Diagnostics Announces Presentation of Promising Glioblastoma Research at 2024 GPEN Conference491Vancouver, British Columbia--(Newsfile Corp. - July 15, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company"), a leading developer of liquid biopsy tests...
► Artikel lesen
18.04.BioMark Diagnostics, Inc.: BioMark Announces Warrant Extension and Granting of Options447Vancouver, British Columbia--(Newsfile Corp. - April 18, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company"), an advanced stage liquid biopsy company...
► Artikel lesen
09.04.BioMark Diagnostics, Inc.: BioMark to Advance Development of Cancer Treatment for Glioblastoma295Vancouver, British Columbia--(Newsfile Corp. - April 9, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company") an advanced stage liquid biopsy company...
► Artikel lesen
28.02.BioMark Diagnostics, Inc.: BioMark Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities402Vancouver, British Columbia--(Newsfile Corp. - February 28, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company"), an advanced stage liquid biopsy company...
► Artikel lesen
26.02.BioMark Diagnostics, Inc.: Theresa Peterson Joins Biomark's Advisory Team475Vancouver, British Columbia--(Newsfile Corp. - February 26, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") an advanced-stage liquid biopsy company with a focus...
► Artikel lesen
29.12.23BioMark Diagnostics, Inc.: BioMark Announces Closing of $1.9 Million Non-Brokered Private Placement631Vancouver, British Columbia--(Newsfile Corp. - December 29, 2023) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company"), an advanced stage liquid biopsy company...
► Artikel lesen
04.12.23BioMark Diagnostics, Inc.: BioMark Announces Recent New Patent Granted in Canada to Support Its Liquid Biopsy Based Legacy Assay672Vancouver, British Columbia--(Newsfile Corp. - December 4, 2023) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company") a clinical and diagnostic laboratory...
► Artikel lesen
28.11.23BioMark Diagnostics, Inc.: BioMark Provides Second Quarter Operational Update and Announces Extension to Warrant Exercise Term564Vancouver, British Columbia--(Newsfile Corp. - November 28, 2023) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company") an advanced stage liquid biopsy company...
► Artikel lesen
17 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1